Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.05 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |